Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

JUNE 6, 2024

Whether you’re looking to refine your market strategy, innovate more effectively, or enhance your competitive advantage, mastering competitor analysis is your key to sustained success and growth. This helps provide a broader context for the external factors influencing your competitive landscape.

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

Alpha Sense BI

MARCH 28, 2023

Third Bridges recognizes its shortcomings in its offerings—if you’re facing a unique business problem that has no pre-existing content offering potential solutions, you can take advantage of Third Bridge Forum or Connections. Who uses expert networks?

Value Chain 52

Value Chain Biotech Research Competitive 52

Evalueserve

DECEMBER 6, 2021

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. These companies will be able to reshape the competitive landscape of the pharmaceutical industry.

Capital 98

Capital Globalization Marketing Marketing 98